Jove
Visualize
Contact Us

Related Experiment Videos

Activity prediction of some nontested anticancer compounds using GA-based PLS regression models.

Sisir Nandi1, Manish C Bagchi

  • 1Structural Biology and Bioinformatics Division, Indian Institute of Chemical Biology (CSIR), 4 Raja S.C. Mullick Road, Jadavpur, Calcutta 700032, India.

Chemical Biology & Drug Design
|July 15, 2011
PubMed
Summary

This study developed a 3D-QSAR model for anticancer drug discovery, predicting activity for novel compounds targeting epidermal growth factor kinase. The model utilizes molecular field analysis and genetic algorithms for enhanced accuracy.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To explore molecular targets and combination antimalarial chemotherapeutics as tissue and erythrocytic schizonticides.

Journal of parasitic diseases : official organ of the Indian Society for Parasitology·2026
Same author

An update on PDGFR inhibitors: a patent review (2020 - present).

Expert opinion on therapeutic patents·2026
Same author

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same author

Cyclic Peptides in Wound Hydrogels: Current Advances and Future Directions.

Current drug discovery technologies·2026
Same author

Quantitative Structure-Activity-Amino Acid Relationship of Benzodiazepines and Thienodiazepine via Molecular Docking Simulation.

Current drug discovery technologies·2025
Same author

To Combat Abnormal Cell Signaling Mediated Gastrointestinal Cancer by Therapeutic Modulation of Gut Microbiota Utilizing Prebiotics, Postbiotics, and Synbiotics.

Current cancer drug targets·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • 6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7(8H)-one derivatives exhibit anticancer properties.
  • Inhibition of epidermal growth factor kinase is a key mechanism for anticancer activity.

Purpose of the Study:

  • To develop a 3D-QSAR model for 6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7(8H)-one compounds.
  • To identify structural features contributing to anticancer activity.
  • To predict the biological activities of novel synthesized compounds.

Main Methods:

  • Computed molecular descriptors and molecular field analysis (MFA).
  • Genetic algorithm (GA) feature selection combined with partial least squares (PLS) regression.
  • A novel QSAR model validation approach using random normalization correction.

Related Experiment Videos

Main Results:

  • A robust 3D-QSAR model was successfully formulated.
  • Steric, electrostatic, and hydrophobic fields were identified as crucial for activity.
  • The model accurately predicted the biological activities of newly synthesized compounds.

Conclusions:

  • The developed 3D-QSAR model provides a valuable tool for designing novel anticancer agents.
  • The findings facilitate structure-based drug design targeting epidermal growth factor kinase.
  • The novel validation approach enhances the reliability of QSAR predictions.